A Malawian pharmaceutical response to the COVID-19 Pandemic.

IF 1.2 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Malawi Medical Journal Pub Date : 2022-03-01 DOI:10.4314/mmj.v34i1.11

Baxter Kachingwe, Peter Kumpalume, Felix Khuluza, Kumbukani Nyirenda, Ernest Matambo, John Mponda, Nettie Dzabala, Francis Chiumia, Ibrahim Chikowe, Frider Chimimba, Nelson Nyoloka, Louisa Alfazema, Happy Nyirongo, Dallas Smith

{"title":"A Malawian pharmaceutical response to the COVID-19 Pandemic.","authors":"Baxter Kachingwe, Peter Kumpalume, Felix Khuluza, Kumbukani Nyirenda, Ernest Matambo, John Mponda, Nettie Dzabala, Francis Chiumia, Ibrahim Chikowe, Frider Chimimba, Nelson Nyoloka, Louisa Alfazema, Happy Nyirongo, Dallas Smith","doi":"10.4314/mmj.v34i1.11","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time.</p>","PeriodicalId":18185,"journal":{"name":"Malawi Medical Journal","volume":"34 1","pages":"60-62"},"PeriodicalIF":1.2000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/c0/MMJ3401-0060.PMC10230587.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malawi Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4314/mmj.v34i1.11","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time.

查看原文本刊更多论文

马拉维应对COVID-19大流行的药物措施。

由于疫情的严重性，COVID-19大流行引发了迅速和创新的应对措施。世界各地开设药学专业的高等教育机构已经发现了COVID-19护理方面的重大差距，并采取了积极措施，帮助抗击冠状病毒。在马拉维，Kamuzu卫生科学大学药学系开始生产世界卫生组织(世卫组织)推荐的一种改进配方的洗手液。这一生产项目包括动员药学教师，确定供应和设备方面的差距，并利用基于证据的信息来生产一种高质量的卫生产品，该产品通过了马拉维标准局的测试要求。药剂科正在扩大产品的分发，以满足一线保健工作者和弱势群体的需求。鉴于马拉维在获得医疗服务方面的历史问题，以及COVID-19在医护人员中的传播，这种洗手液对公共卫生系统的应对至关重要。药学系将继续领导马拉维的药学专业，在这一前所未有的时期提供有针对性的干预措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malawi Medical Journal Medicine-General Medicine

CiteScore

1.50

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Driven and guided by the priorities articulated in the Malawi National Health Research Agenda, the Malawi Medical Journal publishes original research, short reports, case reports, viewpoints, insightful editorials and commentaries that are of high quality, informative and applicable to the Malawian and sub-Saharan Africa regions. Our particular interest is to publish evidence-based research that impacts and informs national health policies and medical practice in Malawi and the broader region. Topics covered in the journal include, but are not limited to: - Communicable diseases (HIV and AIDS, Malaria, TB, etc.) - Non-communicable diseases (Cardiovascular diseases, cancer, diabetes, etc.) - Sexual and Reproductive Health (Adolescent health, education, pregnancy and abortion, STDs and HIV and AIDS, etc.) - Mental health - Environmental health - Nutrition - Health systems and health policy (Leadership, ethics, and governance) - Community systems strengthening research - Injury, trauma, and surgical disorders